[Pulmonary hypertension - disease mechanisms]

Area of Science:

• Cardiovascular Medicine
• Pulmonary Medicine
• Pathophysiology

Background:

• Pulmonary hypertension (PH) presents diverse etiologies but shares complex pathophysiology.
• Therapeutic options for PH remain limited despite shared underlying disease mechanisms.
• Distinguishing cause from consequence in PH pathogenesis is challenging.

Purpose of the Study:

• To summarize functional and histological changes in pulmonary arteries in PH.
• To define the roles of endothelium and pulmonary artery myocytes in PH.
• To discuss key pathophysiological mechanisms driving PH.

Main Methods:

• Review of existing literature on PH pathophysiology.
• Analysis of functional changes: vasoconstriction and vasodilation imbalance.
• Examination of morphological changes: vascular remodeling, cell hyperplasia, and extracellular matrix dysregulation.

Main Results:

• PH involves an imbalance between vasoconstriction and vasodilation.
• Morphological changes include pulmonary artery thickening, narrowing, and reduced elasticity.
• These changes increase pulmonary vascular resistance, right ventricular afterload, and lead to right heart failure.

Conclusions:

• Understanding the shared pathophysiological mechanisms is crucial for developing effective PH therapies.
• The interplay between endothelial and myocyte dysfunction drives PH progression.
• Further research into these mechanisms may reveal new therapeutic targets.